BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarchianaki E, Derdas SP, Ntaoukakis M, Vakonaki E, Lagoudaki ED, Lasithiotaki I, Sarchianaki A, Koutsopoulos A, Symvoulakis EK, Spandidos DA, Antoniou KM, Sourvinos G. Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients. Tumour Biol 2014;35:3203-9. [PMID: 24310500 DOI: 10.1007/s13277-013-1419-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Bae JM, Kim EH. Human papillomavirus infection and risk of lung cancer in never-smokers and women: an 'adaptive' meta-analysis. Epidemiol Health 2015;37:e2015052. [PMID: 26602770 DOI: 10.4178/epih/e2015052] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
2 Sawata T, Bando M, Nakayama M, Mato N, Yamasawa H, Takahashi M, Okamoto H, Sugiyama Y. Clinical significance of changes in Torque teno virus DNA titer after chemotherapy in patients with primary lung cancer. Respir Investig 2018;56:173-8. [PMID: 29548656 DOI: 10.1016/j.resinv.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fan X, Yu K, Wu J, Shao J, Zhu L, Zhang J. Correlation between squamous cell carcinoma of the lung and human papillomavirus infection and the relationship to expression of p53 and p16. Tumor Biol 2015;36:3043-9. [DOI: 10.1007/s13277-014-2940-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
4 Zaravinos A. An updated overview of HPV-associated head and neck carcinomas. Oncotarget 2014;5:3956-69. [PMID: 24970795 DOI: 10.18632/oncotarget.1934] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]
5 Zhang W, Wu X, Hu L, Ma Y, Xiu Z, Huang B, Feng Y, Tang X. Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells. Oncol Res 2017;25:843-52. [PMID: 28508744 DOI: 10.3727/096504016X14813880882288] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
6 de Freitas AC, Gurgel AP, de Lima EG, de França São Marcos B, do Amaral CM. Human papillomavirus and lung cancinogenesis: an overview. J Cancer Res Clin Oncol 2016;142:2415-27. [PMID: 27357515 DOI: 10.1007/s00432-016-2197-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
7 Mariano VS, Leal LF, Pastrez PRA, Silva EM, Reis RM, Longatto-Filho A. Lung cancer samples preserved in liquid medium: One step beyond cytology. Diagn Cytopathol 2017;45:915-21. [PMID: 28589673 DOI: 10.1002/dc.23743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Soh H, Venkatesan N, Veena MS, Ravichandran S, Zinabadi A, Basak SK, Parvatiyar K, Srivastava M, Liang LJ, Gjertson DW, Torres JZ, Moatamed NA, Srivatsan ES. Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB. Mol Cell Biol 2016;36:1776-92. [PMID: 27090639 DOI: 10.1128/MCB.00878-15] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
9 Asor E, Stav MY, Simon E, Fahoum I, Sabo E, Ben-Izhak O, Hershkovitz D. Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy. PLoS One 2017;12:e0173760. [PMID: 28288198 DOI: 10.1371/journal.pone.0173760] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
10 Tsyganov MM, Pevzner AM, Ibragimova MK, Deryusheva IV, Litviakov NV. Human papillomavirus and lung cancer: an overview and a meta-analysis. J Cancer Res Clin Oncol 2019;145:1919-37. [PMID: 31236668 DOI: 10.1007/s00432-019-02960-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shikova E, Ivanova Z, Alexandrova D, Shindov M, Lekov A. Human papillomavirus prevalence in lung carcinomas in Bulgaria. Microbiol Immunol 2017;61:427-32. [PMID: 28881043 DOI: 10.1111/1348-0421.12535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hu Y, Ren S, He Y, Wang L, Chen C, Tang J, Liu W, Yu F. Possible Oncogenic Viruses Associated with Lung Cancer. Onco Targets Ther 2020;13:10651-66. [PMID: 33116642 DOI: 10.2147/OTT.S263976] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Silva EM, Mariano VS, Pastrez PRA, Pinto MC, Nunes EM, Sichero L, Villa LL, Scapulatempo-Neto C, Syrjanen KJ, Longatto-Filho A. Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study. Infect Agent Cancer 2019;14:18. [PMID: 31388352 DOI: 10.1186/s13027-019-0235-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Karnosky J, Dietmaier W, Knuettel H, Freigang V, Koch M, Koll F, Zeman F, Schulz C. HPV and lung cancer: A systematic review and meta-analysis. Cancer Rep (Hoboken) 2021;4:e1350. [PMID: 33624444 DOI: 10.1002/cnr2.1350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Xiong WM, Xu QP, Li X, Xiao RD, Cai L, He F. The association between human papillomavirus infection and lung cancer: a system review and meta-analysis. Oncotarget 2017;8:96419-32. [PMID: 29221217 DOI: 10.18632/oncotarget.21682] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
16 Stumbryte A, Gudleviciene Z, Kundrotas G, Dabkeviciene D, Kunickaite A, Cicenas S. Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer. Oncotarget 2018;9:3214-29. [PMID: 29423041 DOI: 10.18632/oncotarget.22756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Li M, Deng F, Qian LT, Meng SP, Zhang Y, Shan WL, Zhang XL, Wang BL. Association between human papillomavirus and EGFR mutations in advanced lung adenocarcinoma. Oncol Lett 2016;12:1953-8. [PMID: 27602120 DOI: 10.3892/ol.2016.4847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Bibaki E, Tsitoura E, Vasarmidi E, Margaritopoulos G, Trachalaki A, Koutoulaki C, Georgopoulou T, Spandidos DA, Tzanakis N, Antoniou KM. miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns. Mol Med Rep 2018;17:7105-12. [PMID: 29568927 DOI: 10.3892/mmr.2018.8778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
19 Yu Y, Liu X, Yang Y, Zhao X, Xue J, Zhang W, Yang A. Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development. Oncol Lett 2015;10:392-8. [PMID: 26171037 DOI: 10.3892/ol.2015.3213] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
20 Liang H, Pan Z, Cai X, Wang W, Guo C, He J, Chen Y, Liu Z, Wang B, He J, Liang W; AME Lung Cancer Cooperative Group. The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer. Transl Lung Cancer Res 2018;7:397-403. [PMID: 30050777 DOI: 10.21037/tlcr.2018.03.16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]